gabexate has been researched along with citric acid, anhydrous in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsuda, O | 1 |
Kano, M; Shimoyama, T; Shintani, S; Wada, M; Yamashita, M | 1 |
Fujimoto, S; Fujita, H; Hazama, Y; Kuhara, K; Moriyama, A; Nishimura, S; Ohtake, C; Sakuma, R | 1 |
3 other study(ies) available for gabexate and citric acid, anhydrous
Article | Year |
---|---|
[Anticoagulation].
Topics: Benzamidines; Blood Coagulation; Citrates; Citric Acid; Gabexate; Guanidines; Heparin; Humans; Molecular Weight; Renal Dialysis | 1991 |
[Anticoagulant in plasmapheresis].
Topics: Anticoagulants; Benzamidines; Biocompatible Materials; Citrates; Citric Acid; Gabexate; Guanidines; Heparin; Humans; Membranes, Artificial; Plasmapheresis | 1991 |
Nafamostat mesilate, a noncalcium compound, as an anticoagulant, induces calcium-dependent haemolysis when infused with packed erythrocytes.
Topics: Anticoagulants; Benzamidines; Calcium; Citrates; Citric Acid; Drug Evaluation, Preclinical; Edetic Acid; Erythrocyte Membrane; Erythrocytes; Flow Cytometry; Gabexate; Glucose; Guanidines; Hemoglobins; Hemolysis; Humans; In Vitro Techniques; Infusion Pumps; Infusions, Intravenous; L-Lactate Dehydrogenase; Membrane Lipids; Phosphatidylserines; Solutions | 2012 |